Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 218

1.

Mixed treatment comparison of a two-compound formulation (TCF) product containing calcipotriol and betamethasone dipropionate with other topical treatments in psoriasis vulgaris.

van de Kerkhof P, de Peuter R, Ryttov J, Jansen JP.

Curr Med Res Opin. 2011 Jan;27(1):225-38. doi: 10.1185/03007995.2010.541005. Epub 2010 Dec 13. Review.

PMID:
21142833
2.

The effectiveness of two-compound formulation calcipotriol and betamethasone dipropionate gel in the treatment of moderately severe scalp psoriasis: a systematic review of direct and indirect evidence.

Bottomley JM, Taylor RS, Ryttov J.

Curr Med Res Opin. 2011 Jan;27(1):251-68. doi: 10.1185/03007995.2010.541022. Epub 2010 Dec 13. Review.

PMID:
21142838
3.

Cost effectiveness of the two-compound formulation calcipotriol and betamethasone dipropionate gel in the treatment of scalp psoriasis in Scotland.

Affleck AG, Bottomley JM, Auland M, Jackson P, Ryttov J.

Curr Med Res Opin. 2011 Jan;27(1):269-84. doi: 10.1185/03007995.2010.541023. Epub 2010 Dec 13. Review.

PMID:
21142836
4.

The two-compound formulation of calcipotriol and betamethasone dipropionate for treatment of moderately severe body and scalp psoriasis - an introduction.

Freeman K.

Curr Med Res Opin. 2011 Jan;27(1):197-203. doi: 10.1185/03007995.2010.540985. Epub 2010 Dec 13.

PMID:
21142834
6.

A new scalp formulation of calcipotriol plus betamethasone dipropionate compared with each of its active ingredients in the same vehicle for the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.

van de Kerkhof PC, Hoffmann V, Anstey A, Barnes L, Bolduc C, Reich K, Saari S, Segaert S, Vaillant L.

Br J Dermatol. 2009 Jan;160(1):170-6. doi: 10.1111/j.1365-2133.2008.08927.x. Epub 2008 Nov 25.

PMID:
19067709
7.

A new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris.

Douglas WS, Poulin Y, Decroix J, Ortonne JP, Mrowietz U, Gulliver W, Krogstad AL, Larsen FG, Iglesias L, Buckley C, Bibby AJ.

Acta Derm Venereol. 2002;82(2):131-5.

PMID:
12125943
8.

Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris.

Kragballe K, Noerrelund KL, Lui H, Ortonne JP, Wozel G, Uurasmaa T, Fleming C, Estebaranz JL, Hanssen LI, Persson LM.

Br J Dermatol. 2004 Jun;150(6):1167-73.

PMID:
15214905
10.

A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.

Jemec GB, Ganslandt C, Ortonne JP, Poulin Y, Burden AD, de Unamuno P, Berne B, Figueiredo A, Austad J.

J Am Acad Dermatol. 2008 Sep;59(3):455-63. doi: 10.1016/j.jaad.2008.04.027.

PMID:
18694678
11.

A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet/Daivobet/Taclonex) in the treatment of psoriasis vulgaris.

Kragballe K, Austad J, Barnes L, Bibby A, de la Brassinne M, Cambazard F, Fleming C, Heikkilä H, Jolliffe D, Peyri J, Svensson A, Toole J, Wozel G.

Br J Dermatol. 2006 Jun;154(6):1155-60.

PMID:
16704648
12.

Calcipotriol plus betamethasone dipropionate gel compared with its active components in the same vehicle and the vehicle alone in the treatment of psoriasis vulgaris: a randomised, parallel group, double-blind, exploratory study.

Fleming C, Ganslandt C, Guenther L, Johannesson A, Buckley C, Simon JC, Stegmann H, Vestergaard Tingleff L.

Eur J Dermatol. 2010 Jul-Aug;20(4):465-71. doi: 10.1684/ejd.2010.0948. Epub 2010 Apr 23.

PMID:
20413372
13.
14.

Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial.

Kragballe K, Hoffmann V, Ortonne JP, Tan J, Nordin P, Segaert S.

Br J Dermatol. 2009 Jul;161(1):159-66. doi: 10.1111/j.1365-2133.2009.09116.x. Epub 2009 Mar 26.

PMID:
19416259
15.
16.

Efficacy results of a 52-week, randomised, double-blind, safety study of a calcipotriol/betamethasone dipropionate two-compound product (Daivobet/Dovobet/Taclonex) in the treatment of psoriasis vulgaris.

Kragballe K, Austad J, Barnes L, Bibby A, de la Brassinne M, Cambazard F, Fleming C, Heikkilä H, Williams Z, Peyri Rey J, Svensson A, Toole J, Wozel G.

Dermatology. 2006;213(4):319-26.

PMID:
17135738
17.

Calcipotriol plus betamethasone dipropionate scalp formulation is effective and well tolerated in the treatment of scalp psoriasis: a phase II study.

Buckley C, Hoffmann V, Shapiro J, Saari S, Cambazard F, Milsgaard M.

Dermatology. 2008;217(2):107-13. doi: 10.1159/000130425. Epub 2008 May 8.

PMID:
18463448
19.

The DESIRE study--psoriasis patients' satisfaction with topical treatment using a fixed combination of calcipotriol and betamethasone dipropionate in daily clinical practice.

Claréus BW, Houwing R, Sindrup JH, Wigchert S.

Eur J Dermatol. 2009 Nov-Dec;19(6):581-5. doi: 10.1684/ejd.2009.0767. Epub 2009 Sep 2.

PMID:
19726275
20.

Supplemental Content

Support Center